Lili Zhang
Company: Aprinoia Therapeutics Inc.
Job title: Senior Vice President & Head of Preclinical Development
Seminars:
Tau Degrader for Alzheimer’s & Primary Tauopathies: From Platform Development to Translation 3:15 pm
Overview of misfolded protein aggregates for targeted protein degradation Review of technologies and pathways being pursued for tau degrader drug development Future directions of translating tau degrader to drug in clinicsRead more
day: Conference Day Two